ResearcherShanghai Jiao Tong UniversityActive in the last 2 years
Yihao Liu
Matched on ORCID iD 0000-0002-1411-7256; OpenAlex author ID A5045957969. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 32
2022: 1 paper · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper
Papers 5
- CTCF enhances pancreatic cancer progression via FLG-AS1-dependent epigenetic regulation and macrophage polarization. Co-author DOI 10.1038/s41418-024-01423-1↗
- BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1. Co-author DOI 10.1002/advs.202306298↗
- ATF3-induced activation of NF-κB pathway results in acquired PARP inhibitor resistance in pancreatic adenocarcinoma. Co-author DOI 10.1007/s13402-023-00907-5↗
- High CTCF expression mediated by FGD5-AS1/miR-19a-3p axis is associated with immunosuppression and pancreatic cancer progression. Co-author DOI 10.1016/j.heliyon.2023.e22584↗
- The CTCF/LncRNA-PACERR complex recruits E1A binding protein p300 to induce pro-tumour macrophages in pancreatic ductal adenocarcinoma via directly regulating P… Co-author DOI 10.1002/ctm2.654↗
Closest collaborators
The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yizhi Cao · 4 shared papers, 2022–2025 · strength 0.65
- Paper ATF3-induced activation of NF-κB pathway results in acquired PARP inhibitor resistance in pancreatic adenocarcinoma. DOI 10.1007/s13402-023-00907-5↗
- Paper CTCF enhances pancreatic cancer progression via FLG-AS1-dependent epigenetic regulation and macrophage polarization. DOI 10.1038/s41418-024-01423-1↗
- Paper BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1. DOI 10.1002/advs.202306298↗
- Baiyong Shen · 4 shared papers, 2022–2025 · strength 0.65
- Paper ATF3-induced activation of NF-κB pathway results in acquired PARP inhibitor resistance in pancreatic adenocarcinoma. DOI 10.1007/s13402-023-00907-5↗
- Paper CTCF enhances pancreatic cancer progression via FLG-AS1-dependent epigenetic regulation and macrophage polarization. DOI 10.1038/s41418-024-01423-1↗
- Paper BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1. DOI 10.1002/advs.202306298↗
- Shuyu Zhai · 3 shared papers, 2024–2025 · strength 0.52
- Paper ATF3-induced activation of NF-κB pathway results in acquired PARP inhibitor resistance in pancreatic adenocarcinoma. DOI 10.1007/s13402-023-00907-5↗
- Paper CTCF enhances pancreatic cancer progression via FLG-AS1-dependent epigenetic regulation and macrophage polarization. DOI 10.1038/s41418-024-01423-1↗
- Paper BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1. DOI 10.1002/advs.202306298↗
- Pengyi Liu · 3 shared papers, 2024–2025 · strength 0.52
- Paper ATF3-induced activation of NF-κB pathway results in acquired PARP inhibitor resistance in pancreatic adenocarcinoma. DOI 10.1007/s13402-023-00907-5↗
- Paper CTCF enhances pancreatic cancer progression via FLG-AS1-dependent epigenetic regulation and macrophage polarization. DOI 10.1038/s41418-024-01423-1↗
- Paper BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1. DOI 10.1002/advs.202306298↗
- Youwei Zhu · 3 shared papers, 2022–2024 · strength 0.47
- Paper ATF3-induced activation of NF-κB pathway results in acquired PARP inhibitor resistance in pancreatic adenocarcinoma. DOI 10.1007/s13402-023-00907-5↗
- Paper BHLHE40 Inhibits Ferroptosis in Pancreatic Cancer Cells via Upregulating SREBF1. DOI 10.1002/advs.202306298↗
- Paper The CTCF/LncRNA-PACERR complex recruits E1A binding protein p300 to induce pro-tumour macrophages in pancreatic ductal … DOI 10.1002/ctm2.654↗
- Jiayu Lin · 2 shared papers, 2024–2025 · strength 0.37
- Paper ATF3-induced activation of NF-κB pathway results in acquired PARP inhibitor resistance in pancreatic adenocarcinoma. DOI 10.1007/s13402-023-00907-5↗
- Paper CTCF enhances pancreatic cancer progression via FLG-AS1-dependent epigenetic regulation and macrophage polarization. DOI 10.1038/s41418-024-01423-1↗
- Wenxin Qi · 2 shared papers, 2023–2025 · strength 0.36
- Paper CTCF enhances pancreatic cancer progression via FLG-AS1-dependent epigenetic regulation and macrophage polarization. DOI 10.1038/s41418-024-01423-1↗
- Paper High CTCF expression mediated by FGD5-AS1/miR-19a-3p axis is associated with immunosuppression and pancreatic cancer pr… DOI 10.1016/j.heliyon.2023.e22584↗
- Xiaomei Tang · 2 shared papers, 2024 · strength 0.34
- Weishen Wang · 2 shared papers, 2024 · strength 0.34
- Yang Liu · 2 shared papers, 2024 · strength 0.34
- Chenlei Wen · 2 shared papers, 2024–2025 · strength 0.33
- Chenghong Peng · 2 shared papers, 2022–2024 · strength 0.28
- Xiaxing Deng · 2 shared papers, 2022–2024 · strength 0.28
- Xiaxing Deng · 1 shared paper, 2024 · strength 0.19
- Jiewei Lin · 1 shared paper, 2025 · strength 0.18
- Jiancheng Wang · 1 shared paper, 2025 · strength 0.18
- Siyi Zou · 1 shared paper, 2025 · strength 0.18
- Kai Qin · 1 shared paper, 2025 · strength 0.18
- Liu Yang · 1 shared paper, 2025 · strength 0.18
- Shaohua Song · 1 shared paper, 2023 · strength 0.18
- Jiejie Qin · 1 shared paper, 2024 · strength 0.15
- Lijie Han · 1 shared paper, 2024 · strength 0.15
- Dongfeng Cheng · 1 shared paper, 2024 · strength 0.15
- Hao Chen · 1 shared paper, 2024 · strength 0.15
- Lingxi Jiang · 1 shared paper, 2024 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.